GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allmed Medical Products Co Ltd (SZSE:002950) » Definitions » Beneish M-Score

Allmed Medical Products Co (SZSE:002950) Beneish M-Score : -2.78 (As of May. 26, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Allmed Medical Products Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.78 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Allmed Medical Products Co's Beneish M-Score or its related term are showing as below:

SZSE:002950' s Beneish M-Score Range Over the Past 10 Years
Min: -18.06   Med: -2.36   Max: 53.08
Current: -2.78

During the past 10 years, the highest Beneish M-Score of Allmed Medical Products Co was 53.08. The lowest was -18.06. And the median was -2.36.


Allmed Medical Products Co Beneish M-Score Historical Data

The historical data trend for Allmed Medical Products Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allmed Medical Products Co Beneish M-Score Chart

Allmed Medical Products Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.83 -2.36 53.08 -3.07 -2.65

Allmed Medical Products Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.83 -3.02 -2.87 -2.65 -2.78

Competitive Comparison of Allmed Medical Products Co's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Allmed Medical Products Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allmed Medical Products Co's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allmed Medical Products Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Allmed Medical Products Co's Beneish M-Score falls into.



Allmed Medical Products Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Allmed Medical Products Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2924+0.528 * 1.2878+0.404 * 1.007+0.892 * 0.6668+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.82+4.679 * -0.107424-0.327 * 0.8757
=-2.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ¥423 Mil.
Revenue was 746.413 + 738.379 + 591.568 + 612.076 = ¥2,688 Mil.
Gross Profit was 214.849 + 167.769 + 158.038 + 170.196 = ¥711 Mil.
Total Current Assets was ¥1,877 Mil.
Total Assets was ¥5,154 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,960 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥95 Mil.
Total Current Liabilities was ¥1,286 Mil.
Long-Term Debt & Capital Lease Obligation was ¥147 Mil.
Net Income was 93.879 + -40.005 + -6.634 + 29.155 = ¥76 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 187.78 + -35.754 + 252.294 + 225.688 = ¥630 Mil.
Total Receivables was ¥490 Mil.
Revenue was 814.642 + 1143.341 + 932.733 + 1141.389 = ¥4,032 Mil.
Gross Profit was 272.642 + 377.027 + 291.834 + 431.448 = ¥1,373 Mil.
Total Current Assets was ¥2,022 Mil.
Total Assets was ¥5,409 Mil.
Property, Plant and Equipment(Net PPE) was ¥2,014 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥174 Mil.
Total Current Liabilities was ¥1,609 Mil.
Long-Term Debt & Capital Lease Obligation was ¥109 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(422.54 / 2688.436) / (490.333 / 4032.105)
=0.157169 / 0.121607
=1.2924

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1372.951 / 4032.105) / (710.852 / 2688.436)
=0.340505 / 0.264411
=1.2878

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1877.394 + 1959.768) / 5153.553) / (1 - (2022.411 + 2014.275) / 5408.683)
=0.255434 / 0.253666
=1.007

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2688.436 / 4032.105
=0.6668

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 2014.275)) / (0 / (0 + 1959.768))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(95.289 / 2688.436) / (174.29 / 4032.105)
=0.035444 / 0.043226
=0.82

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((147.453 + 1285.95) / 5153.553) / ((108.997 + 1608.828) / 5408.683)
=0.278139 / 0.317605
=0.8757

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(76.395 - 0 - 630.008) / 5153.553
=-0.107424

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Allmed Medical Products Co has a M-score of -2.78 suggests that the company is unlikely to be a manipulator.


Allmed Medical Products Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Allmed Medical Products Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Allmed Medical Products Co (SZSE:002950) Business Description

Traded in Other Exchanges
N/A
Address
Taoyuan Road, 19th Floor, Block A,Taurus Plaza, No.8, Danshan District, Shenzhen, CHN
Allmed Medical Products Co Ltd is engaged in Research & Development, manufacturing and distribution of medical dressings and other disposable medical supplies, with a focus on medical and health activities. The company's products are exported to the United States, Canada, Germany, Japan, the Middle East, and other international markets or regions.
Executives
Chen Hao Hua Director
Peng Xi Yun Supervisors
Huang Wen Jian Directors, executives
Cheng Hong Directors, executives

Allmed Medical Products Co (SZSE:002950) Headlines

No Headlines